Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

TRIM22 Antikörper (N-Term)

TRIM22 Reaktivität: Human WB Wirt: Kaninchen Polyclonal RB33242 unconjugated
Produktnummer ABIN1881901
  • Target Alle TRIM22 Antikörper anzeigen
    TRIM22 (Tripartite Motif Containing 22 (TRIM22))
    Bindungsspezifität
    • 15
    • 7
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 67-96, N-Term
    Reaktivität
    • 42
    • 1
    • 1
    • 1
    Human
    Wirt
    • 37
    • 5
    Kaninchen
    Klonalität
    • 39
    • 3
    Polyklonal
    Konjugat
    • 17
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser TRIM22 Antikörper ist unkonjugiert
    Applikation
    • 34
    • 13
    • 13
    • 11
    • 5
    • 4
    • 4
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB)
    Aufreinigung
    This antibody is purified through a protein A column, followed by peptide affinity purification.
    Immunogen
    This TRIM22 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 67-96 amino acids from the N-terminal region of human TRIM22.
    Klon
    RB33242
    Isotyp
    Ig Fraction
  • Applikationshinweise
    WB: 1:1000
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Buffer
    Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C,-20 °C
    Haltbarkeit
    6 months
  • Kajaste-Rudnitski, Pultrone, Marzetta, Ghezzi, Coradin, Vicenzi: "Restriction factors of retroviral replication: the example of Tripartite Motif (TRIM) protein 5 alpha and 22." in: Amino acids, Vol. 39, Issue 1, pp. 1-9, (2010) (PubMed).

    Petersson, Lönnbro, Herr, Mörgelin, Gullberg, Drott: "The human IFN-inducible p53 target gene TRIM22 colocalizes with the centrosome independently of cell cycle phase." in: Experimental cell research, Vol. 316, Issue 4, pp. 568-79, (2010) (PubMed).

    Ovsyannikova, Dhiman, Haralambieva, Vierkant, OByrne, Jacobson, Poland: "Rubella vaccine-induced cellular immunity: evidence of associations with polymorphisms in the Toll-like, vitamin A and D receptors, and innate immune response genes." in: Human genetics, Vol. 127, Issue 2, pp. 207-21, (2010) (PubMed).

    Ovsyannikova, Haralambieva, Dhiman, OByrne, Pankratz, Jacobson, Poland: "Polymorphisms in the vitamin A receptor and innate immunity genes influence the antibody response to rubella vaccination." in: The Journal of infectious diseases, Vol. 201, Issue 2, pp. 207-13, (2009) (PubMed).

    Gao, Duan, Xu, Xiong: "Tripartite motif-containing 22 inhibits the activity of hepatitis B virus core promoter, which is dependent on nuclear-located RING domain." in: Hepatology (Baltimore, Md.), Vol. 50, Issue 2, pp. 424-33, (2009) (PubMed).

  • Target
    TRIM22 (Tripartite Motif Containing 22 (TRIM22))
    Andere Bezeichnung
    TRIM22 (TRIM22 Produkte)
    Hintergrund
    The protein encoded by this gene is a member of the tripartite motif (TRIM) family. The TRIM motif includes three zinc-binding domains, a RING, a B-box type 1 and a B-box type 2, and a coiled-coil region. This protein localizes to the cytoplasm and its expression is induced by interferon. The protein down-regulates transcription from the HIV-1 LTR promoter region, suggesting that function of this protein may be to mediate interferon's antiviral effects.
    Molekulargewicht
    56947
    NCBI Accession
    NP_001186502, NP_006065
    UniProt
    Q8IYM9
Sie sind hier:
Kundenservice